IL6 and acute respiratory distress syndrome: Plasma and bronchoalveolar levels of several cytokines, including IL‐6, have been identified as one of many biomarkers of lung injury and are also associated with morbidity and mortality in coronavirus disease 2019 (COVID‐19)‐associated ARDS.